Company news

Santhera Pharmaceuticals Holding AG news in 2025

Santhera Pharmaceuticals Holding AG's news releases, calls and decks from 2025, newest first.

View company

Santhera Closes USD 13 Million Royalty Monetization Agreement

November 5, 2025

Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

November 4, 2025

Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia

October 9, 2025

Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

October 3, 2025

Santhera Provides Update on Convertible Bond Issued on 23 September 2025

September 25, 2025

Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update

September 23, 2025

Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout

September 23, 2025

Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India

August 29, 2025

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

August 19, 2025

Santhera extends Highbridge convertible bond to 30th September 2025

August 15, 2025

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

August 13, 2025

Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

May 20, 2025

Santhera Publishes Agenda for its Annual General Meeting

April 29, 2025

Santhera Full Year Results for the Year Ended 31 December 2024

April 29, 2025

Santhera shares updates on commercial rollout of AGAMREE®

April 16, 2025

Santhera proposes Dr. Melanie Rolli as new member of Board of Directors

March 27, 2025

Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day

March 24, 2025

Full Year Trading Update

March 4, 2025

Calls in 2025

Decks in 2025